(Q50520431)

14 March 2018

title

Reversal of liver fibrosis by the antagonism of endocannabinoid CB1 receptor in a rat model of CCl(4)-induced advanced cirrhosis. (English)

1 reference

14 March 2018

0 references

0 references

Giacomo Zaccherini

4

0 references

author name string

Ferdinando A Giannone

1

1 reference

14 March 2018

Maurizio Baldassarre

2

1 reference

14 March 2018

Marco Domenicali

3

1 reference

14 March 2018

Franco Trevisani

5

1 reference

14 March 2018

Mauro Bernardi

6

1 reference

14 March 2018

Paolo Caraceni

7

1 reference

14 March 2018

publication date

19 December 2011

1 reference

14 March 2018

published in

Laboratory Investigation

1 reference

14 March 2018

volume

92

1 reference

14 March 2018

issue

3

1 reference

14 March 2018

page(s)

384-395

1 reference

14 March 2018

https://scigraph.springernature.com/pub.10.1038/labinvest.2011.191

exact match

0 references

cites work

Endocannabinoids and liver disease. II. Endocannabinoids in the pathogenesis and treatment of liver fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

Antifibrogenic role of the cannabinoid receptor CB2 in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

An introduction to the endocannabinoid system: from the early to the latest concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

The role of the endocannabinoid system in liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

Cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

A novel sodium overload test predicting ascites decompensation in rats with CCl4-induced cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

The endocannabinoid system as an emerging target of pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

Role of the endocannabinoid system in food intake, energy homeostasis and regulation of the endocrine pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischaemia-reperfusion injury complicated by endotoxaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

Role of matrix metalloprotease-2 in oxidant activation of Ca2+ ATPase by hydrogen peroxide in pulmonary vascular smooth muscle plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

Anandamide induces necrosis in primary hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

Oval cell numbers in human chronic liver diseases are directly related to disease severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

Endothelin antagonism in portal hypertensive mice: implications for endothelin receptor-specific signaling in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

Lack of inducible nitric oxide synthase leads to increased hepatic apoptosis and decreased fibrosis in mice after chronic carbon tetrachloride administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

Interleukin-10 therapy--review of a new approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

Effect of interleukin-10 and platelet-derived growth factor on expressions of matrix metalloproteinases-2 and tissue inhibitor of metalloproteinases-1 in rat fibrotic liver and cultured hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

Effects of interleukin-10 on activation and apoptosis of hepatic stellate cells in fibrotic rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

Cytokine receptor signaling through the Jak-Stat-Socs pathway in disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

JAK-STAT signaling in hepatic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-beta1 production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

Expression of matrix metalloproteinase-2 and -14 persists during early resolution of experimental liver fibrosis and might contribute to fibrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

Antifibrotic activity of anisodamine in vivo is associated with changed intrahepatic levels of matrix metalloproteinase-2 and its inhibitor tissue inhibitors of metalloproteinases-2 and transforming growth factor beta1 in rats with carbon tetrachlor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

Dynamic changes in the expression of matrix metalloproteinases and their inhibitors, TIMPs, during hepatic fibrosis induced by alcohol in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

The relationship between endotoxemia and hepatic endocannabinoids in cirrhotic rats with portal hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

Regression of fibrosis after chronic stimulation of cannabinoid CB2 receptor in cirrhotic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

Endocannabinoids in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

7 January 2021

CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

7 January 2021

A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

7 January 2021

New insights into the molecular mechanism of interleukin-10-mediated immunosuppression

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

7 January 2021

Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

7 January 2021

Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

7 January 2021

Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.191

7 January 2021

10.1038/LABINVEST.2011.191

Identifiers

DOI

1 reference

14 March 2018

release_e7hrhoe6fncq3o3t5w6sfdf3w4

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/e7hrhoe6fncq3o3t5w6sfdf3w4

24 November 2022

mapped directly with Wikidata item

1 reference

14 March 2018